Nira Bar-Ner

Title: Nira Bar-Ner: Innovator in Pharmaceutical Development

Introduction

Nira Bar-Ner is a prominent inventor based in Rishon Letzion, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystalline forms of compounds that act as muscarinic acetylcholine receptor agonists. With a total of six patents to her name, her work has the potential to impact the treatment of various diseases and disorders.

Latest Patents

One of Nira Bar-Ner's latest patents involves the creation of crystalline polymorphs of a muscarinic acetylcholine receptor agonist. This patent describes isolated crystalline polymorphs of (S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro[4.5]decane-3-one, which exhibit favorable properties for pharmaceutical manufacturing. The patent also outlines methods for preparing these crystalline polymorphs and converting them into one another. Additionally, it includes methods for preparing medicaments that incorporate these compounds, which are suitable for treating conditions that respond to modulation of the muscarinic acetylcholine receptor.

Career Highlights

Throughout her career, Nira Bar-Ner has worked with esteemed organizations such as the Israel Institute for Biological Research and Nsc Therapeutics GmbH. Her experience in these institutions has allowed her to refine her expertise in pharmaceutical research and development.

Collaborations

Nira has collaborated with notable colleagues, including Abraham Fisher and Yishai Karton. These partnerships have contributed to her innovative work and the advancement of her research.

Conclusion

Nira Bar-Ner is a trailblazer in the field of pharmaceutical innovation, with her patents paving the way for new treatments. Her contributions to the development of muscarinic acetylcholine receptor agonists highlight her commitment to advancing medical science.